Real-world use of MRI for risk stratification prior to prostate biopsy.
Mohammad R SiddiquiBrandon AnsbroParth V ShahJonathan A AguiarEric V LiJordan M RichAshorne K MahenthiranSoliman A S MoatazMary-Kate KeeterQuan MaiXinlei MiEdward M SchaefferAshley Evan RossPublished in: Prostate cancer and prostatic diseases (2022)
Use of MRI as a risk stratification tool for elevated PSA rose during this 4-year study period. Men who self-identify as black or men with Medicaid coverage have diminished rates of MRI usage. Considerable provider-level variability in MRI use was observed. Future research aimed at identifying factors affecting implementation of MRI as a routine risk assessment tool is warranted.